Lucence Diagnostics Pte LTD
Lucence is a precision oncology company that makes state-of-the-art, highly sensitive liquid biopsy tests for disease detection and treatment selection. LiquidHALLMARK, Lucence’s flagship test, is swift, simple, and sensitive and covers a wide range of clinically relevant biomarkers, including mutations, fusions and somatic variants. Lucence is headquartered in Palo Alto and Singapore, and its services are delivered worldwide through a CLIA-licensed and CAP-accredited central laboratory. Follow us on Twitter @lucencedx, and visit www.lucence.com for more information.